AN2 Therapeutics exchanges 2.8M common shares for pre-funded warrants with Coastlands Capital

AN2 Therapeutics, Inc.

Exchanged 2,500,000 shares of common stock for pre-funded warrant for 2,500,000 shares on June 17, 2025.
Exchanged additional 300,000 shares for pre-funded warrant for 300,000 shares on June 19, 2025.
Warrants have $0.00001 exercise price, no expiration, and beneficial ownership blocker at 9.99% (up to 19.99%).
Issued under Section 3(a)(9) exemption from registration; form of warrant filed as Exhibit 4.1.

item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.